Literature DB >> 11331381

Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants.

K Mukhida1, K A Baker, D Sadi, I Mendez.   

Abstract

One of the critical variables that influences the efficacy of clinical neural transplantation for Parkinson's disease (PD) is optimal graft placement. The current transplantation paradigm that focuses on ectopic placement of fetal grafts in the striatum (ST) fails to reconstruct the basal ganglia circuitry or normalize neuronal activity in important basal ganglia structures, such as the substantia nigra (SN) and the subthalamic nucleus (STN). The aim of this study was to investigate a multitarget neural transplantation strategy for PD by assessing whether simultaneous dopaminergic transplants in the ST, SN, and STN induce functional recovery in hemiparkinsonian rats. Forty-six female Wistar rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway were randomly divided into eight groups and received lesions only or injections of 900,000 embryonic rat ventral mesencephalic cells in the (1) ST, (2) SN, (3) STN, (4) ST and SN, (5) ST, SN, and STN, (6) ST and STN, or (7) SN and STN. The number of cells transplanted was equally divided among grafting sites. Animals with two grafts received 450,000 cells in each structure, and animals with three grafts received 300,000 cells per structure. Recovery was assessed by amphetamine-induced rotations and the stepping tests. Graft survival was assessed using tyrosine hydroxylase immunohistochemistry. At 8 weeks after transplantation, simultaneous dopaminergic transplants in the ST, SN, and STN induced significant improvement in rotational behavior and stepping test scores. Intrastriatal transplants were associated with significant recovery of rotational asymmetry, whereas SN and STN transplants were associated with improved forelimb function scores. These results suggest that restoration of dopaminergic activity to multiple basal ganglia targets, such as the ST and SN, or the ST and STN, promotes a more complete functional recovery of complex sensorimotor behaviors. A multitarget transplant strategy aimed at optimizing dopaminergic reinnervation of the basal ganglia may be crucial in improving clinical outcomes in PD patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331381      PMCID: PMC6762505     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  73 in total

1.  Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

Authors:  G K Wenning; P Odin; P Morrish; S Rehncrona; H Widner; P Brundin; J C Rothwell; R Brown; B Gustavii; P Hagell; M Jahanshahi; G Sawle; A Björklund; D J Brooks; C D Marsden; N P Quinn; O Lindvall
Journal:  Ann Neurol       Date:  1997-07       Impact factor: 10.422

Review 2.  Update on fetal transplantation: the Swedish experience.

Authors:  O Lindvall
Journal:  Mov Disord       Date:  1998       Impact factor: 10.338

Review 3.  Neural transplantation in Parkinson's disease.

Authors:  V Mehta; J Spears; I Mendez
Journal:  Can J Neurol Sci       Date:  1997-11       Impact factor: 2.104

4.  Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus.

Authors:  I Mintz; C Hammond; J Féger
Journal:  Brain Res       Date:  1986-06-04       Impact factor: 3.252

5.  Hemiballism: report of 25 cases.

Authors:  A Vidaković; N Dragasević; V S Kostić
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

6.  A direct role of dopamine in the rat subthalamic nucleus and an adjacent intrapeduncular area.

Authors:  L L Brown; M H Markman; L I Wolfson; B Dvorkin; C Warner; R Katzman
Journal:  Science       Date:  1979-12-21       Impact factor: 47.728

7.  Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients.

Authors:  C François; C Savy; C Jan; D Tande; E C Hirsch; J Yelnik
Journal:  J Comp Neurol       Date:  2000-09-11       Impact factor: 3.215

8.  Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.

Authors:  J H Kordower; T B Freeman; B J Snow; F J Vingerhoets; E J Mufson; P R Sanberg; R A Hauser; D A Smith; G M Nauert; D P Perl
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

9.  Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.

Authors:  M Olsson; G Nikkhah; C Bentlage; A Björklund
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

10.  The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.

Authors:  H Bergman; T Wichmann; B Karmon; M R DeLong
Journal:  J Neurophysiol       Date:  1994-08       Impact factor: 2.714

View more
  15 in total

1.  Orthotopic transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the substantia nigra of hemiparkinsonian rats induces neuronal differentiation and motoric improvement.

Authors:  Stefan Jean-Pierre Haas; Stanislav Petrov; Golo Kronenberg; Oliver Schmitt; Andreas Wree
Journal:  J Anat       Date:  2007-11-23       Impact factor: 2.610

2.  The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats.

Authors:  Timothy P Gilmour; Brigitte Piallat; Christopher A Lieu; Kala Venkiteswaran; Renuka Ramachandra; Anand N Rao; Andrew C Petticoffer; Matthew A Berk; Thyagarajan Subramanian
Journal:  Brain       Date:  2011-09-12       Impact factor: 13.501

3.  Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results.

Authors:  Oscar Arias-Carrión; Eric Murillo-Rodriguez; Man Xu; Carlos Blanco-Centurion; Rene Drucker-Colín; Priyattam J Shiromani
Journal:  Sleep       Date:  2004-12-15       Impact factor: 5.849

4.  Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

Authors:  Ivar Mendez; Rosario Sanchez-Pernaute; Oliver Cooper; Angel Viñuela; Daniela Ferrari; Lars Björklund; Alain Dagher; Ole Isacson
Journal:  Brain       Date:  2005-05-04       Impact factor: 13.501

5.  Disruption of mitochondrial complex I induces progressive parkinsonism.

Authors:  Patricia González-Rodríguez; Enrico Zampese; Kristen A Stout; Jaime N Guzman; Ema Ilijic; Ben Yang; Tatiana Tkatch; Mihaela A Stavarache; David L Wokosin; Lin Gao; Michael G Kaplitt; José López-Barneo; Paul T Schumacker; D James Surmeier
Journal:  Nature       Date:  2021-11-03       Impact factor: 69.504

6.  Extrastriatal dopaminergic circuits of the Basal Ganglia.

Authors:  Karen S Rommelfanger; Thomas Wichmann
Journal:  Front Neuroanat       Date:  2010-10-27       Impact factor: 3.856

7.  Recovery from experimental parkinsonism by semaphorin-guided axonal growth of grafted dopamine neurons.

Authors:  N Emmanuel Díaz-Martínez; Elisa Tamariz; N Fabián Díaz; Claudia M García-Peña; Alfredo Varela-Echavarría; Iván Velasco
Journal:  Mol Ther       Date:  2013-06-04       Impact factor: 11.454

8.  Semaphorin 3C Released from a Biocompatible Hydrogel Guides and Promotes Axonal Growth of Rodent and Human Dopaminergic Neurons.

Authors:  Oscar A Carballo-Molina; Andrea Sánchez-Navarro; Adolfo López-Ornelas; Rolando Lara-Rodarte; Patricia Salazar; Aurelio Campos-Romo; Verónica Ramos-Mejía; Iván Velasco
Journal:  Tissue Eng Part A       Date:  2016-06       Impact factor: 3.845

9.  Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior.

Authors:  Veronica A Antipova; Carsten Holzmann; Oliver Schmitt; Andreas Wree; Alexander Hawlitschka
Journal:  Front Behav Neurosci       Date:  2017-06-21       Impact factor: 3.558

Review 10.  Restoring lost nigrostriatal fibers in Parkinson's disease based on clinically-inspired design criteria.

Authors:  Wisberty J Gordián-Vélez; Dimple Chouhan; Rodrigo A España; H Isaac Chen; Jason A Burdick; John E Duda; D Kacy Cullen
Journal:  Brain Res Bull       Date:  2021-07-28       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.